Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04978155
Other study ID # ECHO FAV
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2020
Est. completion date July 1, 2021

Study information

Verified date July 2021
Source University Paul Sabatier of Toulouse
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Preoperative vascular mapping with echo-Doppler is acknowledged as indispensable to create an arteriovenous fistula for haemodialysis (AVF). The conditions for performing this examination are not always ideal (venous vasospasm in cool temperatures, variability of the volume status in the dialysis patient). On the other hand, the use of a loco-regional anaesthesia (LRA) results in the vasodilation of the limb thus rendering it possible to use the veins which were initially considered too small. The aim of this study is to assess the functionality of our AVF when ultrasound identification was used by the surgeon after the LRA. These results have been compared with those of the preceding year during which this identification was not implemented.


Description:

The investigators conducted a prospective study in the year 2020 during which all the patients (n=90) had an AVF creation with preoperative venous identification by the surgeon at university hospital of TOULOUSE (France)(echo group). All the patients gave their consent, and the database was anonymised upon completion. All patients were seen in a preoperative consultation with venous mapping carried out by a physician specialised in the use of Doppler ultrasonography. Following this consultation, a type of fistula was programmed in accordance with the Silva criteria (notably a vein with a diameter of over 2.5mm and an artery of 2mm). On the day of the operation, loco-regional anaesthesia was performed under sonographic guidance according to the previous description . The decision of the block approach and the choice of local aesthetic agent was left to the discretion of the anaesthesiologist. The surgeon carried out an ultrasound and modification of the type of AVF was then made if the Silva criteria differed from those described during initial consultation. The modification could be a more distal creation, a more proximal creation, a change of vein or a change of artery. The investigators succeeded to create more distal AVF when the vein had a diameter of over 2.5mm after LRA. Furthermore, the investigators reassembled the AVF when the vein appeared too small or residual (for example, following the attachment of an infusion having occurred between mapping and the surgery). The same team of 4 surgeons participated in the creation of the AVF for both the echo group and the control group. All patients were given a preoperative assessment of their heart function and cardiovascular risk factors (HTA, diabetes, smoking, dyslipidaemia). Prior strokes and coronary diseases were also registered as well as the patients' BMI and American society of anesthesiology score. The definition of the good development of the haemodialysis access is based on the National Kidney Foundation's criteria: Blood flow>600ml, diameter over 6mm and lower depth of 6mm. On the other hand, permeability was based on the criteria of the Society for Vascular Surgery : primary permeability lasts from the creation to the first dilation episode or transposition of anastomosis required to maintain the access. Assisted primary permeability ends at the time of the first occlusion episode. Secondary permeability ends with the abandonment or the definitive withdrawal of the AVF due to failure. The first postoperative consultation took place at around the 6th week after the creation which is the normal time necessary for the smooth development of an AVF . The investigators compared all these results with our control group which consists of all the patients who had a native AVF placed during the year 2019 without having received immediate preoperative ultrasound and therefore there was no alteration in the surgical project in relation to that planned at the time of the consultation. Demographic data was similarly compiled and all the evaluation criteria compared


Recruitment information / eligibility

Status Completed
Enrollment 193
Est. completion date July 1, 2021
Est. primary completion date February 1, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Native AVF access - During the year 2020 - Preoperative mapping during the consultation - Loco-regional anesthesia Exclusion Criteria: - Redo surgery

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Duplex ultrasound performed by the surgeon after locoregional anesthesia
Just after locoregional anesthesia, the surgeon perform a duplex ultrasound to determinate if the target vessel chosen to create the arterio-venous fistulae match with the pre-operative duplex performed during the consultation. So the plan can be changed such as more distal, more proximal creation, changing vein or artery target.

Locations

Country Name City State
France aurelien Hostalrich Toulouse

Sponsors (1)

Lead Sponsor Collaborator
University Paul Sabatier of Toulouse

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Functionality of the AVF at the time of the postoperative An AVF is defined as functional if all the criteria of the good development of the haemodialysis access (based on the National Kidney Foundation's criteria) are present : Blood flow>600ml, diameter over 6mm and lower depth of 6mm 6 weeks
Secondary The rate of planning change between the surgical project at the time of the consultation and the AVF that is finally placed During the surgery
Secondary Primary, assisted primary and secondary permeability of our accesses permeability was based on the criteria of the Society for Vascular Surgery : primary permeability lasts from the creation to the first dilation episode or transposition of anastomosis required to maintain the access. Assisted primary permeability ends at the time of the first occlusion episode. Secondary permeability ends with the abandonment or the definitive withdrawal of the AVF due to failure 12 months
See also
  Status Clinical Trial Phase
Completed NCT03246984 - VALUE- Vascular Access Laminate eUropean Experience. A Post Market Surveillance Study to Assess the Safety and Effectiveness of VasQ N/A
Withdrawn NCT03538392 - Serranator® Alto Post Market Clinical Follow Up (PMCF) Study
Completed NCT03044496 - NIRS Measurement After SCP Block
Recruiting NCT03054623 - Hemodynamic Assessment of Distal Revascularization Interval Ligation N/A
Completed NCT05801549 - Arterio-Venous Fistula Audit. Successful Utilisation Rates of Arterio-Venous Fistulae for Haemodialysis at University Hospital Limerick
Completed NCT04011072 - Far Infrared Therapy on Arteriovenous Fistulas in Hemodialysis Patients N/A
Completed NCT03242343 - VasQ External Support for Arteriovenous Fistula N/A
Not yet recruiting NCT06336226 - Brachio Basilic Arterio Venous Fistula One Stage vs Two Stage N/A
Recruiting NCT06091839 - Anchor Versus Parachute Suturing Technique in Arteriovenous Fistula Creation for Hemodialysis N/A
Enrolling by invitation NCT04381754 - Use of Implanting the Biotronik Passeo-18 Lux Drug Coated Balloon to Treat Failing Haemodialysis Arteriovenous Fistulas and Grafts.
Enrolling by invitation NCT04054440 - Outpatient Office Based Endovascular Procedures
Completed NCT03988270 - Prefistula Forearm Exercise in Pts Requiring Chronic HD Therapy N/A
Completed NCT04925635 - Fistula Care and Mobile Health Applications in Hemodialysis Patients
Completed NCT04177901 - The Use of NIRS in Brachial Plexus Block N/A
Completed NCT04222881 - End-to-side Versus Side-to-side Anastomosis With Distal Vein Ligation for Arteriovenous Fistula Creation
Recruiting NCT03853070 - Post Market Clinical Follow-Up for ED Coil / Electro-detach Generator v4
Completed NCT04293614 - Invasive Arterio-Venous Fistula Blood Pressure Monitoring & Fluid Dynamics Study
Recruiting NCT03731000 - PHIL® Embolic System Pediatric IDE N/A